Related Experiment Video
Updated: Jun 14, 2025
08:22
Measurement of 3-Dimensional cAMP Distributions in Living Cells using 4-Dimensional x, y, z, and λ Hyperspectral FRET Imaging and Analysis
Published on: October 27, 2020
3.9K
PDE3A as a Therapeutic Target for the Modulation of Compartmentalised Cyclic Nucleotide-Dependent Signalling
Swaroop Ranjan Pati1,2, Anastasiia Sholokh1,3, Enno Klussmann1,3
1Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
Cells
|June 11, 2025
Summary
Phosphodiesterase 3A (PDE3A) regulates cyclic AMP (cAMP) signaling pathways crucial for cellular functions. Targeting PDE3A offers therapeutic potential for various diseases linked to dysregulated cAMP signaling.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Biochemistry
Background:
- Phosphodiesterase 3A (PDE3A) hydrolyzes cyclic AMP (cAMP), a key second messenger.
- PDE3A regulates cAMP levels in diverse cellular compartments, influencing critical cellular processes.
- Dysregulation of cAMP signaling is implicated in various pathological conditions.
Purpose of the Study:
- To review the known functions of PDE3A in cellular signaling.
- To explore emerging therapeutic strategies targeting PDE3A.
- To highlight the potential of PDE3A modulation for disease treatment.
Main Methods:
- Literature review of PDE3A functions and therapeutic targeting strategies.
- Analysis of PDE3A's role in different cellular compartments and processes.
- Examination of current and future approaches for PDE3A modulation.
Main Results:
- PDE3A plays a significant role in controlling cAMP signaling with spatial and temporal accuracy.
- Its expression in various cell types impacts muscle contractility, gene expression, differentiation, and proliferation.
- Current therapeutic approaches focus on PDE3A's catalytic domain and cellular localization.
Conclusions:
- Understanding PDE3A's functions is key to unlocking its therapeutic potential.
- Targeting PDE3A offers promising avenues for treating diseases associated with cAMP dysregulation.
- Further research into specific PDE3A modulators is warranted for clinical applications.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
136
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
136
01:11IP3/DAG Signaling Pathway
11.9K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.9K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
01:28Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
01:16Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K